Company:
Talking Medicines Limited
Management Team:
Jo Halliday, CEO; Dr Elizabeth Fairley, COO; Dr Scott Crae, MRCVS CMO; Chairman, Clovis Younger; Special Advisor, Ben Cons
Web & Social Media:
talkingmedicines.com
@TMedicines
gomedsmart.com
@GoMedsmart
Value Proposition:
Selling Medsmart® insights data - what really happens to medicines after the patient leave the pharmacy. Medsmart® is a digital tool to measure patient engagement and support.
Customer Segments:
Pharmaceutical Company Brand Managers
Market Traction:
Traction with customers in Q4 2018 and strong sales funnel for 2019.
Awards:
£100k from the Scottish Enterprise Unlocking Ambition Competition
Funding Stage:
Seed
Funding and Investment to Date:
High net worth individuals
Post Money Valuation:
>£1m
Investment Sought:
£600k
DISCLAIMER
The purpose of this Investor Showcase is to provide information on the business described above. The Investor Showcase is not a prospectus and does not constitute or form any offer or invitation to subscribe for, underwrite, or purchase securities, nor shall the Investor Showcase or any part of it form the basis of, or be relied upon in connection with, any contract relating to any securities unless expressly included hereafter.
WARNING
The content of this Investor Showcase has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this Investor Showcase for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.
Talking Medicines Limited
Management Team:
Jo Halliday, CEO; Dr Elizabeth Fairley, COO; Dr Scott Crae, MRCVS CMO; Chairman, Clovis Younger; Special Advisor, Ben Cons
Web & Social Media:
talkingmedicines.com
@TMedicines
gomedsmart.com
@GoMedsmart
Value Proposition:
Selling Medsmart® insights data - what really happens to medicines after the patient leave the pharmacy. Medsmart® is a digital tool to measure patient engagement and support.
Customer Segments:
Pharmaceutical Company Brand Managers
Market Traction:
Traction with customers in Q4 2018 and strong sales funnel for 2019.
Awards:
£100k from the Scottish Enterprise Unlocking Ambition Competition
Funding Stage:
Seed
Funding and Investment to Date:
High net worth individuals
Post Money Valuation:
>£1m
Investment Sought:
£600k
DISCLAIMER
The purpose of this Investor Showcase is to provide information on the business described above. The Investor Showcase is not a prospectus and does not constitute or form any offer or invitation to subscribe for, underwrite, or purchase securities, nor shall the Investor Showcase or any part of it form the basis of, or be relied upon in connection with, any contract relating to any securities unless expressly included hereafter.
WARNING
The content of this Investor Showcase has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this Investor Showcase for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.
